McGinn Penninger Investment Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-274,603
Closed -$2.3M 29
2022
Q2
$2.3M Buy
274,603
+78,542
+40% +$1.1M 1.82% 25
2022
Q1
$4.48M Buy
196,061
+33,500
+21% +$819K 3% 15
2021
Q4
$4.49M Sell
162,561
-437
-0.3% -$11.7K 2.97% 13
2021
Q3
$4.54M Buy
162,998
+325
+0.2% +$9.22K 3.27% 9
2021
Q2
$4.77M Buy
+162,673
New +$4.93M 3.41% 9

Other funds holding BHC

McGinn Penninger Investment Management's BHC Position: Q3 2022 in Review

McGinn Penninger Investment Management sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 274,603 shares — an estimated $2.3M sold.

McGinn Penninger Investment Management first reported a position in BHC in Q2 2021 and held it in 5 quarters. The position peaked at $4.77M in Q2 2021. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • McGinn Penninger Investment Management reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • McGinn Penninger Investment Management sold 274,603 Bausch Health shares in Q3 2022, an estimated $2.3M.
  • McGinn Penninger Investment Management first reported a position in Bausch Health in Q2 2021 and held it in 5 quarters.
  • McGinn Penninger Investment Management's Bausch Health position peaked at $4.77M in Q2 2021.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on McGinn Penninger Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.